Navigation Links
Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
Date:1/20/2009

ST. JOSEPH, Mich., Jan. 20 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that the Department of Energy's Pacific Northwest National Laboratory (PNNL) has become a certified GeneGo Center of Excellence. PNNL researchers will have institution-wide access to GeneGo's MetaCore data analysis suite, training and advanced support. PNNL advances the science and technology to address complex national challenges in fundamental science as well as energy, environment and national security. MetaCore will be used throughout many research programs both as a central data repository, management and collaboration platform for OMICs data analysis and as an integrative pathway analysis suite.

"PNNL has been a long time GeneGo customer and the user base is continuously growing," said Julie Bryant, GeneGo's VP of Business development. "They are taking advantage of our EZ search data mining tools that quickly provides answers to their systems biology and pathway questions."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flag
'/>"/>

SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing
2. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
3. Quintiles Expands Base for Growing Asia-Pacific Operations
4. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
5. American Pacific to Release Financial Results and Hold Fiscal 2008 Third Quarter Investor Teleconference
6. Pacific Biosciences Raises $100 Million to Fund Commercial Product Development
7. PacificGMP to Merge With Pacific Biopharma Group and Create Innovative US-Compliant cGMP Contract Biomanufacturing Facility in China
8. Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI-COR Biosciences
9. Aton Pharma Announces Distribution Partnership in the Asia Pacific Region
10. BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center
11. PacifiCare Capitulates to Latest Patient Revolt
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6
Breaking Biology News(10 mins):AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Genome BC collaborates with Chile and Norway to sequence salmon genome 2White, but not pure 2White, but not pure 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 1New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 2New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 4New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 5StoredIQ Shares Expertise at IQPCs eDiscovery Pharma Biotech and Medical Device Conference 13978 1StoredIQ Shares Expertise at IQPCs eDiscovery Pharma Biotech and Medical Device Conference 13978 2Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection 56753 1Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection 56753 2Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection 56753 3